Your browser doesn't support javascript.
loading
Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study.
Kim, Yu Ri; Kim, Jin Seok; Kim, Won Seog; Eom, Hyeon Seok; Yang, Deok-Hwan; Bae, Sung Hwa; Kim, Hyo Jung; Lee, Jae Hoon; Oh, Suk-Joong; Yoon, Sung-Soo; Kwak, Jae-Yong; Choi, Chul Won; Kim, Min Kyoung; Oh, Sung Young; Kang, Hye Jin; Nam, Seung Hyun; Shim, Hyeok; Park, Joon Seong; Mun, Yeung-Chul; Suh, Cheolwon.
Affiliation
  • Kim YR; Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Kim JS; Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Kim WS; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Eom HS; Hematology-Oncology Clinic, National Cancer Center, Goyang, Korea.
  • Yang DH; Department of Hematology/Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea.
  • Bae SH; Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu, Korea.
  • Kim HJ; Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.
  • Lee JH; Departments of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
  • Oh SJ; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Yoon SS; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Kwak JY; Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Korea.
  • Choi CW; Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
  • Kim MK; Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea.
  • Oh SY; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.
  • Kang HJ; Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
  • Nam SH; Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, Korea.
  • Shim H; Department of Internal Medicine, Wonkwang University School of Medicine, Iksan, Korea.
  • Park JS; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea.
  • Mun YC; Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea.
  • Suh C; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Cancer Res Treat ; 55(4): 1355-1362, 2023 Oct.
Article in En | MEDLINE | ID: mdl-36996864
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prednisolone / Lymphoma, Large B-Cell, Diffuse Type of study: Clinical_trials Limits: Humans / Male Language: En Journal: Cancer Res Treat Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prednisolone / Lymphoma, Large B-Cell, Diffuse Type of study: Clinical_trials Limits: Humans / Male Language: En Journal: Cancer Res Treat Year: 2023 Document type: Article Country of publication: